Allocations
Wasserstein & Co, on behalf of its private equity fund Wasserstein Partners III, has acquired Moss Inc (Moss), a provider of highly engineered, three-dimensional fabric structures and customised environmental branding solutions. Terms of the acquisition have not been disclosed.
Founded in 1975, and headquartered in Elk Grove, IL, Moss transforms physical environments into powerful branded experiences. Moss’ three-dimensional visual communication structures and displays enrich marketing and merchandising venues, including retail destinations, tradeshows, corporate environments, museums and entertainment events. The Company is a differentiated, total solutions provider that serves its customers’ unique needs from project visualisation and design conception to production
Salvepar has sold MultiPlan Group to Helman & Friedman for EUR29.7 million, which equates to a 3.7x multiple on the firm’s original investment.
Salvepar originally invested USD20 million in the acquisition of MultiPlan alongside Starr Investment Holdings in March 2014. The closing of the sale transaction is expected to take place before the end of Q2 2016.
Investec Bank’s globally recognised aviation finance arm has successfully closed a USD1 billion operating lease transaction with Emirates Airline, the world’s largest operator of the Airbus A380 and Boeing 777 aircraft.
The USD1 billion transaction has facilitated the delivery and sale and leaseback of four A380-800s, the world’s largest passenger jet, to Dubai-headquartered Emirates over the past four months. The aircraft involved are of 2013 and 2016 vintages. Investec has acquired the 2013 vintages aircraft from Stellwagen Finance, the holding company for Aviation Finance Company (AFC). The 2016 deliveries are new deliveries direct from Airbus.
Investec acted as the sole
Investment bank GCA Savvian Corporation and financial advisory group Altium are to merge to form an independent international investment bank focused on growth companies with an extensive global network, cross-border capability and track record of industry-shaping transactions.
The combined company will operate under the names GCA Altium in Europe and GCA in the United States and Asia.
Upon the completion of the transaction, GCA will be a leading global pure play advisory business with a focus on growth companies and the 7th largest listed M&A advisory firm in the world, with more than USD185 million in advisory revenues, approximately 370 staff, 300
Infrastructure investments have held up over the past five years but political and regulatory risk dominates investors’ lists of concerns according to the latest infrastructure investors survey from Deloitte, the business advisory firm.
Deloitte surveyed 25 European infrastructure investors, including infrastructure funds and direct lenders, together holding over GBP200 billion in assets and ‘dry powder’, for its 2016 survey, the fourth in its series.
92 per cent of respondents say their infrastructure investments have proved resilient over the last five years, with 8 per cent saying performance has been mixed
Investors have cut their target internal rates of
ACT Genomics, an integrated cancer molecular information company that transforms precision cancer care, has raised USD 12.5 million in Series B funding.
Hotung Group, and CDIB Capital Management, led the round with continued participation from existing investors, Eminent II VC, Hua Nan Venture Capital, President International Development and UMC Capital in this round.
Based in Taipei, Taiwan, ACT Genomics is providing comprehensive genomic profiling assays and molecular information to physicians and biopharmaceutical customers. With full spectrum of clinical service, ACT Genomics helps to expand targeted therapy treatment options, predict response to immune-checkpoint inhibitors, and utilise ctDNA based assay to monitor
New research from BNY Mellon finds that private equity, real estate and infrastructure managers anticipate strong growth in assets in the next five years. The research, Building for the future: How alternative investment managers are rising to the demographic challenge, was prepared in collaboration with Preqin, finds that global macro-economic, social and environmental shifts are fuelling a need for investments in real assets, property and infrastructure worldwide.
The report forecasts that appetite for these assets among retail and institutional investors will continue to grow. Sixty per cent of infrastructure managers, 44 per cent of real estate managers and 39 per
Humanyze, a specialist in people analytics technology, has secured USD4 million in Series A financing from Romulus Capital.
The announcement comes as Humanyze rolls out the first of its kind Wyze people analytics platform to its strong Fortune 500 customer base in the US and industry leaders in Japan with the goal of making large corporations more agile and accurate about their most valuable resource (people), and to make these same people more in control of their performance and improvement.
“Our customers – which include the largest multinationals and consulting firms – are investing heavily in technology and personnel to
Ogier is acting as British Virgin Islands legal counsel to Atlantic Alliance Partnership Corp on its recently announced recommended offer for TLA Worldwide plc.
TLA Worldwide plc (TLA) is a leading athlete representation, sports marketing and event management company which represents a number of prominent US and International sports stars, broadcasters and media personalities.
TLA also provides a range of services in respect of media consultancy, sports sponsorship and events. TLA is a public company incorporated in England with its shares are listed on the AIM market of the London Stock Exchange. Atlantic’s offer for TLA, which was announced under
venBio Partners has held the closing of the venBio Global Strategic Fund II, its second life sciences venture capital fund, for a total of approximately USD315 million, exceeding its target of USD250 million.
venBio's Strategic Fund II is anchored by major investments from three strategic limited partners – Amgen, Merck, and Baxalta – along with a group of financial Limited Partners.
"We believe our fund model is unique. With the return of Amgen and Baxalta, along with the addition of Merck, the commitment from our Strategic Limited Partners is now larger than ever," says Robert Adelman, MD, managing partner at
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
